Effects of time of estrogen deprivation on anxiety-like behavior and GABAA receptor plasticity in ovariectomized rats

Behavioural Brain Research

Volumn 246, Issue , 2013, Pages 86-93

  Daendee, Suwaporn ^a   Thongsong, Boonrit ^a   Kalandakanond Thongsong, Sarinee ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Anxiety; Estrogen; ETM; GABAA receptor; Ovariectomized rat

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA2; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA3; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA4; ESTROGEN; MESSENGER RNA;

AMINO ACID SEQUENCE; AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ANXIETY DISORDER; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DISEASE ASSOCIATION; ESTROGEN DEFICIENCY; FEMALE; FOOD INTAKE; GAMMA AMINOBUTYRIC ACID A RECEPTOR ALPHA 2 SUBUNIT GENE; GAMMA AMINOBUTYRIC ACID A RECEPTOR ALPHA 3 SUBUNIT GENE; GENE; GENE EXPRESSION; LATENT PERIOD; LOCOMOTION; MAZE TEST; MESENCEPHALON; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN FIELD TEST; OVARIECTOMY; PLASTICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RESPONSE TIME; UTERUS WEIGHT;

ANALYSIS OF VARIANCE; ANIMALS; ANXIETY; BODY WEIGHT; BRAIN; DISEASE MODELS, ANIMAL; EATING; ESCAPE REACTION; ESTROGENS; EXPLORATORY BEHAVIOR; FEMALE; GENE EXPRESSION REGULATION; MAZE LEARNING; OVARIECTOMY; PROTEIN SUBUNITS; RANDOM ALLOCATION; RATS; RATS, WISTAR; REACTION TIME; RECEPTORS, GABA-A; RNA, MESSENGER; TIME FACTORS; UTERUS;

EID: 84875682614     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.03.008     Document Type: Article

References (84)

1. Lim L., Ng T.P., Chua H.C., Chiam P.C., Won V., Lee T., et al. Generalised anxiety disorder in Singapore: prevalence, co-morbidity and risk factors in a multi-ethnic population. Social Psychiatry and Psychiatric Epidemiology 2005, 40:972-979.
2. Seeman M.V. Psychopathology in women and men: focus on female hormones. American Journal of Psychiatry 1997, 154:641-647.
3. Avis N.E., Crawford S., Stellato R., Longcope C. Longitudinal study of hormone levels and depression among women transitioning through menopause. Climacteric 2001, 4:243-249.
4. Schmidt P.J. Depression, the perimenopause, and estrogen therapy. Annals of the New York Academy of Sciences 2005, 1052:27-40.
5. Ditkoff E.C., Crary W.G., Cristo M., Lobo R.A. Estrogen improves psychological function in asymptomatic postmenopausal women. Obstetrics and Gynecology 1991, 78:991-995.
6. Schmidt P.J., Nieman L., Danaceau M.A., Tobin M.B., Roca C.A., Murphy J.H., et al. Estrogen replacement in perimenopause-related depression: a preliminary report. American Journal of Obstetrics and Gynecology 2000, 183:414-420.
7. Zeidan M.A., Igoe S.A., Linnman C., Vitalo A., Levine J.B., Klibanski A., et al. Estradiol modulates medial prefrontal cortex and amygdala activity during fear extinction in women and female rats. Biological Psychiatry 2011, 70:920-927.
8. Hiroi R., Neumaier J.F. Complex roles of estrogen in emotion: sex matters. Biological Psychiatry 2011, 70:908-909.
9. Weiser M.J., Foradori C.D., Handa R.J. Estrogen receptor beta in the brain: from form to function. Brain Research. Brain Research Reviews 2008, 57:309-320.
10. Kalueff A.V., Tuohimaa P. Experimental modeling of anxiety and depression. ACTA Neurobiologiae Experimentalis 2004, 64:439-448.
11. Frick K.M., Burlingame L.A., Arters J.A., Berger-Sweeney J. Reference memory, anxiety and estrous cyclicity in C57BL/6NIA mice are affected by age and sex. Neuroscience 2000, 95:293-307.
12. Morgan M.A., Pfaff D.W. Effects of estrogen on activity and fear-related behaviors in mice. Hormones and Behavior 2001, 40:472-482.
13. Morgan M.A., Pfaff D.W. Estrogen's effects on activity, anxiety, and fear in two mouse strains. Behavioural Brain Research 2002, 132:85-93.
14. Hiroi R., Neumaier J.F. Differential effects of ovarian steroids on anxiety versus fear as measured by open field test and fear-potentiated startle. Behavioural Brain Research 2006, 166:93-100.
15. Pandaranandaka J., Poonyachoti S., Kalandakanond-Thongsong S. Anxiolytic property of estrogen related to the changes of the monoamine levels in various brain regions of ovariectomized rats. Physiology and Behavior 2006, 87:828-835.
16. Walf A.A., Parity Frye C.A. estrogen-administration alter affective behavior of ovariectomized rats. Physiology and Behavior 2008, 93:351-356.
17. Walf A.A., Koonce C.J., Frye C.A. Estradiol or diarylpropionitrile decrease anxiety-like behavior of wildtype, but not estrogen receptor beta knockout, mice. Behavioral Neuroscience 2008, 122:974-981.
18. Pandaranandaka J., Poonyachoti S., Kalandakanond-Thongsong S. Differential effects of exogenous and endogenous estrogen on anxiety as measured by elevated T-maze in relation to the serotonergic system. Behavioural Brain Research 2009, 198:142-148.
19. Walf A.A., Frye C.A. Estradiol reduces anxiety- and depression-like behavior of aged female mice. Physiology and Behavior 2010, 99:169-174.
20. Kalandakanond-Thongsong S., Daendee S., Srikiatkhachorn A. Effect of the acute and chronic estrogen on anxiety in the elevated T-maze. Physiology and Behavior 2012, 105:357-363.
21. Mora S., Dussaubat N., Diaz-Veliz G. Effects of the estrous cycle and ovarian hormones on behavioral indices of anxiety in female rats. Psychoneuroendocrinology 1996, 21:609-620.
22. Galeeva A., Tuohimaa P. Analysis of mouse plus-maze behavior modulated by ovarian steroids. Behavioural Brain Research 2001, 119:41-47.
23. Imwalle D.B., Gustafsson J.A., Rissman E.F. Lack of functional estrogen receptor beta influences anxiety behavior and serotonin content in female mice. Physiology and Behavior 2005, 84:157-163.
24. Walf A.A., Koonce C., Manley K., Frye C.A. Proestrous compared to diestrous wildtype, but not estrogen receptor beta knockout, mice have better performance in the spontaneous alternation and object recognition tasks and reduced anxiety-like behavior in the elevated plus and mirror maze. Behavioural Brain Research 2009, 196:254-260.
25. Carey M.P., Billing A.E., Fry J.P. Fluctuations in responses to diazepam during the oestrous cycle in the mouse. Pharmacology, Biochemistry and Behavior 1992, 41:719-725.
26. Malizia A.L., Cunningham V.J., Bell C.J., Liddle P.F., Jones T., Nutt D.J. Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study. Archives of General Psychiatry 1998, 55:715-720.
27. Reddy D.S., Kulkarni S.K. Sex and estrous cycle-dependent changes in neurosteroid and benzodiazepine effects on food consumption and plus-maze learning behaviors in rats. Pharmacology, Biochemistry and Behavior 1999, 62:53-60.
28. Vanin J.R. Overview of anxiety and the anxiety disorders. Anxiety Disorders: A Pocket Guide for Primary Care 2008, 1-18. Humana Press, New Jersey. J.R. Vanin, J.D. Helsley (Eds.).
29. Abadie P., Boulenger J.P., Benali K., Barre L., Zarifian E., Baron J.C. Relationships between trait and state anxiety and the central benzodiazepine receptor: a PET study. European Journal of Neuroscience 1999, 11:1470-1478.
30. Hasler G., van der Veen J.W., Geraci M., Shen J., Pine D., Drevets W.C. Prefrontal cortical gamma-aminobutyric acid levels in panic disorder determined by proton magnetic resonance spectroscopy. Biological Psychiatry 2009, 65:273-275.
31. Mohler H., Crestani F., Rudolph U. GABA(A)-receptor subtypes: a new pharmacology. Current Opinion in Pharmacology 2001, 1:22-25.
32. Low K., Crestani F., Keist R., Benke D., Brunig I., Benson J.A., et al. Molecular and neuronal substrate for the selective attenuation of anxiety. Science 2000, 290:131-134.
33. A receptors. British Journal of Pharmacology 2005, 144:357-366.
34. Dias R., Sheppard W.F., Fradley R.L., Garrett E.M., Stanley J.L., Tye S.J., et al. Evidence for a significant role of alpha 3-containing GABAA receptors in mediating the anxiolytic effects of benzodiazepines. Journal of Neuroscience 2005, 25:10682-10688.
35. A receptor subtypes mediate the anxiolytic properties of benzodiazepine site ligands in the conditioned emotional response paradigm. European Journal of Neuroscience 2006, 23:2495-2504.
36. A receptor in anxiety: evidence from animal models, molecular and clinical psychopharmacology, and brain imaging studies. Current Neuropharmacology 2003, 1:267-285.
37. Olsen R.W., DeLorey T.M. GABA and glycine. Basic neurochemistry: Molecular, Cellular and Medical Aspects 1999, 335-346. Lippincott-Raven Publishers, Philadelphia. 6th edition. G.J. Siegel, B.W. Agranoff, R.W. Albers, S.K. Fisher, M.D. Uhler (Eds.).
38. Pirker S., Schwarzer C., Wieselthaler A., Sieghart W., Sperk G. GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience 2000, 101:815-850.
39. Heldt S.A., Ressler K.J. Localized injections of midazolam into the amygdala and hippocampus induce differential changes in anxiolytic-like motor activity in mice. Behavioural Pharmacology 2006, 17(4):349-356.
40. dos Reis L.M., Canto-de-Souza A. Intra-periaqueductal gray matter injections of midazolam fail to alter anxiety in plus-maze experienced mice. Brain Research 2008, 1231:93-102.
41. Barbalho C.A., Nunes-de-Souza R.L., Canto-de-Souza A. Similar anxiolytic-like effects following intra-amygdala infusions of benzodiazepine receptor agonist and antagonist: evidence for the release of an endogenous benzodiazepine inverse agonist in mice exposed to elevated plus-maze test. Brain Research 2009, 1267:65-76.
42. A receptor: from molecular mechanisms to CNS role in reproduction, disfunction and drug abuse. Advances in Molecular and Cell Biology 2004, 32:219-250.
43. Picazo O., Estrada-Camarena E., Hernandez-Aragon A. Influence of the post-ovariectomy time frame on the experimental anxiety and the behavioural actions of some anxiolytic agents. European Journal of Pharmacology 2006, 530:88-94.
44. A receptor subunit mRNA expression in preoptic area and bed nucleus of the stria terminalis of female rat brain. Journal of Neuroscience 1995, 15:2328-2337.
45. A receptor in the amygdala after progesterone withdrawal. European Journal of Pharmacology 2003, 17:641-648.
46. A receptor subunit mRNA expression in NT2-N neurons. Molecular Brain Research 2005, 138(2):105-115.
47. Byrnes E.M., Lee J.O., Bridges R.S. Alterations in GABA(A) receptor alpha2 subunit mRNA expression following reproductive experience in rats. Neuroendocrinology 2007, 85:148-156.
48. A receptor-mediated transmission in the hypothalamus: effects on reproductive function. Neuropharmacology 2007, 52:1439-1453.
49. Lovick T.A., Griffiths J.L., Dunn S.M., Martin I.L. Changes in GABA(A) receptor subunit expression in the midbrain during the oestrous cycle in Wistar rats. Neuroscience 2005, 131:397-405.
50. Fiorelli R., Rudolph U., Straub C.J., Feldon J., Yee B.K. Affective and cognitive effects of global deletion of alpha3-containing gamma-aminobutyric acid-A receptors. Behavioural Pharmacology 2008, 19:582-596.
51. A receptors. The Journal of Neuroscience 2012, 32:8611-8619.
52. Graeff F.G., Viana M.B., Tomaz C. The elevated T maze, a new experimental model of anxiety and memory: effect of diazepam. Brazilian Journal of Medical and Biological Research 1993, 26:67-70.
53. Lu N.Z., Eshleman A.J., Janowsky A., Bethea C.L. Ovarian steroid regulation of serotonin reuptake transporter (SERT) binding, distribution, and function in female macaques. Molecular Psychiatry 2003, 8:353-360.
54. Zangrossi H., Graeff F.G. A behavioral validation of the elevated T-maze: a new animal model of anxiety. Brain Research Bulletin 1997, 44:1-5.
55. Custódio Teixeira R.C., Zangrossi JrH, Graeff F.G. Behavioral effects of acute and chronic imipramine in the elevated T-maze model of anxiety. Pharmacology, Biochemistry and Behavior 2000, 65:571-576.
56. McCarthy M.M., Felzenberg E., Robbins A., Pfaff D.W., Schwartz-Giblin S. Infusions of diazepam and allopregnanolone into the midbrain central gray facilitate open-field behavior and sexual receptivity in female rats. Hormones and Behavior 1995, 29:279-295.
57. Heffner T.G., Harman J.A., Seiden L.S. A rapid method for the regional dissection of the rat brain. Pharmacology Biochemistry & Behavior 1980, 13:453-456.
58. Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative C(T) method. Nature Protocols 2008, 3:1101-1108.
59. Frye C.A., Walf A.A. Estrogen and/or progesterone administered systemically or to the amygdala can have anxiety-, fear-, and pain-reducing effects in ovariectomized rats. Behavioral Neuroscience 2004, 118:306-313.
60. Lagunas N., Calmarza-Font I., Diz-Chaves Y., Garcia-Segura L.M. Long-term ovariectomy enhances anxiety and depressive-like behaviors in mice submitted to chronic unpredictable stress. Hormones and Behavior 2010, 58:786-791.
61. Diz-Chaves Y., Kwiatkowska-Naqvi A., Von Hulst H., Pernia O., Carrero P., Garcia-Segura L.M. Behavioral effects of estradiol therapy in ovariectomized rats depend on the age when the treatment is initiated. Experimental Gerontology 2012, 47:93-99.
62. Hsiao C.C., Liu C.Y., Hsiao M.C. No correlation of depression and anxiety to plasma estrogen and progesterone levels in patients with premenstrual dysphoric disorder. Psychiatry and Clinical Neurosciences 2004, 58:593-599.
63. Smith S.S., Gong Q.H., Hsu F.C., Markowitz R.S., ffrench-Mullen J.M., Li X. GABA(A) receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature 1998, 392:926-930.
64. A receptor alpha4 subunit in association with increased anxiety. Journal of Neuroscience 1998, 18:5275-5284.
65. A receptor subunits: plasticity of expression during the estrous cycle. Neuroscience 2005, 136:457-466.
66. Smith S.S., Ruderman Y., Frye C., Homanics G., Yuan M. Steroid withdrawal in the mouse results in anxiogenic effects of 3alpha, 5beta-THP: a possible model of premenstrual dysphoric disorder. Psychopharmacology 2006, 186:323-333.
67. Maguire J.L., Stell B.M., Rafizadeh M., Mody I. Ovarian cycle-linked changes in GABA(A) receptors mediating tonic inhibition alter seizure susceptibility and anxiety. Nature Neuroscience 2005, 8:797-804.
68. Noriega N.C., Eghlidi D.H., Garyfallou V.T., Kohama S.G., Kryger S.G., Urbanski H.F. Influence of 17beta-estradiol and progesterone on GABAergic gene expression in the arcuate nucleus, amygdala and hippocampus of the rhesus macaque. Brain Research 2010, 1307:28-42.
69. Engin E., Liu J., Rudolph U. a2-containing GABA(A) receptors: a target for the development of novel treatment strategies for CNS disorders. Pharmacology & Therapeutics 2012, 136:142-152.
70. Dixon C.I., Rosahl T.W., Stephens D.N. Targeted deletion of the GABRA2 gene encoding alpha2-subunits of GABA(A) receptors facilitates performance of a conditioned emotional response, and abolishes anxiolytic effects of benzodiazepines and barbiturates. Pharmacology, Biochemistry, and Behavior 2008, 90:1-8.
71. A receptor subtypes in mice. Neuropharmacology 2012, 63:250-258.
72. Wafford K.A., Thompson S.A., Thomas D., Sikela J., Wilcox A.S., Whiting P.J. Functional characterization of human gamma-aminobutyric acidA receptors containing the alpha 4 subunit. Molecular Pharmacology 1996, 50:670-678.
73. Gulinello M., Gong Q.H., Li X., Smith S.S. Short-term exposure to a neuroactive steroid increases alpha4 GABA(A) receptor subunit levels in association with increased anxiety in the female rat. Brain Research 2001, 910:55-66.
74. A receptors. Progress in Neurobiology 2003, 71:67-80.
75. Patisaul H.B., Whitten P.L., Young L.J. Regulation of estrogen receptor beta mRNA in the brain: opposite effects of 17beta-estradiol and the phytoestrogen, coumestrol. Brain Research Molecular Brain Research 1999, 67:165-171.
76. Mohamed M.K., Abdel-Rahman A.A. Effect of long-term ovariectomy and estrogen replacement on the expression of estrogen receptor gene in female rats. European Journal of Endocrinology 2000, 142:307-314.
77. Shima N., Yamaguchi Y., Yuri K. Distribution of estrogen receptor beta mRNA-containing cells in ovariectomized and estrogen-treated female rat brain. Anatomical Science International 2003, 78:85-97.
78. Yamada S., Noguchi D., Ito H., Yamanouchi K. Sex and regional differences in decrease of estrogen receptor alpha-immunoreactive cells by estrogen in rat hypothalamus and midbrain. Neuroscience Letters 2009, 463:135-139.
79. Tomihara K., Soga T., Nomura M., Korach K.S., Gustafsson J.A., Pfaff D.W., Ogawa S. Effect of ER-beta gene disruption on estrogenic regulation of anxiety in female mice. Physiology & Behavior 2009, 96:300-306.
80. Oyola M.G., Portillo W., Reyna A., Foradori C.D., Kudwa A., Hinds L., Handa R.J., Mani S.K. Anxiolytic effects and neuroanatomical targets of estrogen receptor-ß (ERß) activation by a selective ERß agonist in female mice. Endocrinology 2012, 153:837-846.
81. A receptors. Journal of Neuroendocrinology 1995, 7:171-177.
82. Reddy D.S., O'Malley B.W., Rogawski M.A. Anxiolytic activity of progesterone in progesterone receptor knockout mice. Neuropharmacology 2005, 48:14-24.
83. Follesa P., Biggio F., Caria S., Gorini G., Biggio G. Modulation of GABA(A) receptor gene expression by allopregnanolone and ethanol. European Journal of Pharmacology 2004, 500:413-425.
84. Maguire J., Mody I. Neurosteroid synthesis-mediated regulation of GABA(A) receptors: relevance to the ovarian cycle and stress. Journal of Neuroscience 2007, 27:2155-2162.